Skip to main content
The driveway to the Kay Jewelers Pavilion on our Akron Campus will be closed for 2-4 weeks beginning Oct. 10. Click HERE for details.
Go to homepage

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Treating Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Description:

For complete study information, please view the study on clinicaltrials.gov.

Interested in participating?
We are currently recruiting
Full IRB Study Title:
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
IRB Study ID:
1038450-1
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research and Stem Cell Transplantation; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program